Cepheid at ADLM designing diagnostics for tomorrow
Cepheid innovations aim to help laboratories scale molecular testing with greater efficiency and confidence
6 Jul 2026As ADLM spotlights the future of laboratory diagnostics, Cepheid is showcasing next-generation molecular innovations designed to help labs expand testing and scale workflows without adding complexity. The focus is on supporting laboratories as they adapt to growing clinical demand while maintaining the workflows they rely on every day.
Cepheid will showcase future-ready molecular diagnostics for laboratory teams at ADLM
Designing diagnostics for tomorrow without disrupting today
Behind every diagnostic result is a laboratory team making high-stakes decisions – balancing speed, accuracy, and efficiency in an environment where expectations continue to rise.
For microbiologists and lab directors, the role has never been more visible, or more critical to patient care.
Today’s laboratories are not just processing tests. They guide clinical decisions, support care pathways, and play a critical role in ensuring healthcare systems operate with confidence.
Rising expectations – and rising to meet them
Across healthcare systems, laboratories are being asked to deliver:
- Broader test menus
- Faster turnaround times
- Greater operational efficiency
And yet, laboratories consistently meet these demands, often navigating staffing constraints, increasing complexity, and evolving clinical needs.
This ability to adapt, scale, and deliver under pressure is what defines today’s leading labs.
Supporting expertise, not adding burden
As laboratories look to the future, the focus is not simply on adding new technology. Instead, it’s on adopting solutions that respect how labs already operate.
Labs are beginning to ask:
- Can we expand testing without fragmenting workflows?
- Can we scale operations without retraining staff?
- Can we add capability without increasing operational burden?
The answer to the question is evident and the underlying priority is clear: the need to build on existing expertise, not disrupt it.
A new approach to diagnostic innovation
At ADLM, Cepheid will share how it is rethinking the role of molecular diagnostics in modern laboratories.
Rather than introducing complexity, the focus is on advancing a broader vision. This is centered on:
- Unified workflows across settings
- Expanded and future-ready testing capabilities
- Operational efficiency at scale
The goal is to enable laboratories to do more within the infrastructure they already trust, while preparing for the demands ahead.
Why this matters now
Today’s lab directors are making decisions that balance immediate operational needs with long-term strategy.
They are evaluating how to:
- Grow testing capabilities
- Support clinical teams more effectively
- Maintain consistency, quality, and reliability under increasing demand
These are not incremental challenges. They are fundamental to how diagnostics supports healthcare.
And they require solutions that are as thoughtful and adaptable as the people leading today’s labs.
What to watch at ADLM
At this year’s meeting, Cepheid will unveil the latest innovation, focused on supporting laboratories as they continue to evolve, scale, and lead. Attendees can visit Cepheid at booth 3237 to learn more about its latest molecular diagnostics innovations and speak with representatives about future-ready laboratory workflows.
For microbiologists and lab directors, the focus remains clear:
How to continue delivering at the highest level, while preparing for what comes next.
Cepheid’s goal is to support that journey – helping laboratories expand what’s possible, without changing what already works.
Connect with Cepheid representatives at ADLM to explore what’s next in a partnership focused on a better way in molecular diagnostics.
Visit cepheid.com to learn more about the latest in molecular diagnostics.
Related products
Request Quote for All Products
GeneXpert System
CepheidCepheid's GeneXpert system family combines speed, accuracy, and simplicity to deliver PCR results anywhere testing is needed. The system automates sample preparation, PCR amplification, and detection using self-contained GeneXpert test cartridges.
GeneXpert Infinity Systems
CepheidThe versatile, automated GeneXpert® Infinity Systems deliver a complete all — in-one molecular diagnostics system to your healthcare institution - a complete on-demand, robotic, molecular lab with an unparalleled user interface. Fast. Flexible. Smart. Fully Automated, Robotic Cartridge Handling Up to 2,074 test results in a mere 24 hour period. Less than 52 minutes time to first result. Less than 2 minutes sample prep time per test. With results like these, clinical healthcare is not only more efficient, it is also more effective. The GeneXpert Infinity System delivers rapid, actionable results to clinicians, fostering a seamless workflow to assist healthcare professionals make more informed patient care decisions. Fully Integrated The Infinity System has smart technology built-in - a fluid master scheduler that prioritizes test runs that meet your always dynamic workflow needs. Smart alerts that keep you informed, enabling walk-away capabilities. Bi-directional connectivity with your LIS and HIS networks, providing seamless communications flow of all incoming and outgoing test orders and results.
Frequently asked questions
How is Cepheid showcasing next-generation molecular diagnostics at ADLM to support modern clinical laboratories?
Cepheid is using ADLM to spotlight next-generation molecular innovations that help laboratories expand testing and scale workflows without adding complexity. The company focuses on unified workflows across settings, expanded and future-ready testing capabilities, and operational efficiency at scale, enabling labs to do more within trusted infrastructure while meeting rising clinical demand.
Why are microbiologists and lab directors central to Cepheid’s vision for future-ready molecular diagnostics?
The article highlights that microbiologists and lab directors now play a highly visible, critical role in patient care. They guide clinical decisions, support care pathways, and maintain consistency, quality, and reliability under increasing demand. Cepheid’s vision centers on supporting their expertise—expanding testing, scaling operations, and improving efficiency—without disrupting existing workflows or requiring extensive retraining.
What can ADLM attendees expect from Cepheid at booth 3237 regarding laboratory workflow innovation?
At ADLM, attendees visiting Cepheid at booth 3237 can learn about the company’s latest molecular diagnostics innovations designed for future-ready laboratory workflows. Cepheid will share how it is rethinking molecular diagnostics to enable broader test menus, faster turnaround times, and greater operational efficiency, helping laboratories expand capabilities and prepare for future demands without increasing operational burden.
